CJC-1295 (No Dac)/Ipamorelin Blend
$110.00
Overview
Research-use GHRH analogue and ghrelin receptor agonist blend supplied for studies of somatotropic-axis and GH/IGF-1 pathway models.
- Concentration
- 10 mg / 10 mg
- Stock
- In stock
Material profile
CJC-1295 (No DAC)/Ipamorelin Blend combines a GHRH analogue with a ghrelin receptor agonist for somatotropic-axis research models. Pattern lists this material for controlled laboratory research.
- Research Targets
- GHRH receptor signaling, ghrelin receptor/GHS-R1a signaling, pituitary somatotroph pathway models.
- Key Feature
- Dual-pathway secretagogue research blend for coordinated endocrine signaling studies.
- Research Focus Areas
- Growth hormone pulse dynamics, IGF-1 pathway signaling, endocrine feedback, metabolic pathway studies.
- Common Models
- Pituitary cell assays, rodent endocrine models, metabolic signaling studies.
- Mechanistic Interests
- cAMP signaling, calcium mobilization, somatotroph activation, hypothalamic-pituitary axis dynamics.
- Use Boundary
- Research use only; not for human or veterinary use; no diagnostic, therapeutic, or consumption use is implied.
Product documentation
Certificate of Analysis
CJC-1295 with DAC
Review the public certificate available for this product before creating an account or checking out.
